A Rare Novel Deletion of the Tyrosine Hydroxylase Gene in Parkinson Disease

Tyrosine hydroxylase (TH) enzyme is a rate limiting enzyme in dopamine biosynthesis. Missense mutation in both alleles of the TH gene is known to cause dopamine‐related phenotypes, including dystonia and infantile Parkinsonism. However, it is not clear if single allele mutation in TH modifies the susceptibility to the adult form of Parkinson disease (PD). We reported a novel deletion of entire TH gene in an adult with PD. The deletion was first identified by copy number variation (CNV) analysis in a genome‐wide association study using Illumina Infinium BeadChips. After screening 635 cases and 642 controls, the deletion was found in one PD case but not in any control. The deletion was confirmed by multiple quantitative PCR (qPCR) assays. There is no additional exonic single nucleotide variant in the one copy of TH gene of the patient. The patient has an age‐at‐onset of 54 years, no evidence for dystonia, and was responsive to L‐DOPA. This case supports the importance of the TH gene in PD pathogenesis and raises more attention to rare variants in candidate genes being a risk factor for Parkinson disease. © 2010 Wiley‐Liss, Inc.

[1]  H. Shang,et al.  GCH1 mutation and clinical study of Chinese patients with dopa‐responsive dystonia , 2010, Movement disorders : official journal of the Movement Disorder Society.

[2]  Eden R Martin,et al.  Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease , 2010, Annals of human genetics.

[3]  D. Zafeiriou,et al.  Tyrosine hydroxylase deficiency with severe clinical course. , 2009, Molecular genetics and metabolism.

[4]  Eden R Martin,et al.  Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. , 2009, American journal of human genetics.

[5]  W. Bodmer,et al.  Common and rare variants in multifactorial susceptibility to common diseases , 2008, Nature Genetics.

[6]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[7]  A. Romstad,et al.  Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early‐onset Parkinson's Disease , 2006, European journal of neurology.

[8]  K. Gunderson,et al.  A genome-wide scalable SNP genotyping assay using microarray technology , 2005, Nature Genetics.

[9]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[10]  S. Kish,et al.  Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations , 2001, Neurology.

[11]  J. Haavik,et al.  Tyrosine hydroxylase and Parkinson's disease , 1998, Molecular Neurobiology.

[12]  D. Schaid,et al.  Validation of a telephone questionnaire for Parkinson's disease. , 1998, Journal of clinical epidemiology.

[13]  J. Cano,et al.  Oxidative inactivation of tyrosine hydroxylase in substantia nigra of aged rat. , 1996, Free radical biology & medicine.